Inspired by the findings that the expression of CD47 is upregulated on the surface of certain cancer cells to avoid phagocytosis, this strategy was achieved by adding a CD47-derived, enzyme-resistant peptide to the surface of the liposome in order to block the RES so that the circulation time of the liposome can be prolonged [14,15]. Here, CD47 is linked to cancer.